AC
GILD icon

Apella Capital’s Gilead Sciences GILD Stock Holding History

Apella Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$424K Buy
2,889
+480
+20% +$67.3K 0.01% 544
2026
Q2 		$329K Buy
2,409
+128
+6% +$16.9K ﹤0.01% 566
2026
Q1 		$314K Buy
+2,281
New +$319K ﹤0.01% 541
2021
Q3 		– Sell
-2,940
Closed -$202K – 207
2021
Q2 		$202K Sell
2,940
-772
-21% -$51.5K 0.03% 204
2021
Q1 		$240K Sell
3,712
-1,134
-23% -$73.1K 0.08% 121
2020
Q4 		$282K Hold
4,846
– – 0.1% 112
2020
Q3 		$306K Buy
4,846
+1
+0% +$69 0.12% 100
2020
Q2 		$373K Buy
4,845
+271
+6% +$20.8K 0.17% 87
2020
Q1 		$342K Buy
+4,574
New +$316K 0.2% 82

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Apella Capital's GILD Position: Q3 2026 in Review

Apella Capital increased its Gilead Sciences (GILD) stake by 20% in Q3 2026, buying an estimated $67.3K and bringing the position to 2,889 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #544.

Apella Capital first reported a position in GILD in Q1 2020 and has held it in 9 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Apella Capital held 2,889 shares of Gilead Sciences worth $424K as of Q3 2026.
  • Apella Capital bought 480 Gilead Sciences shares in Q3 2026, an estimated $67.3K.
  • Gilead Sciences made up 0.01% of Apella Capital's portfolio in Q3 2026, its #544 holding.
  • Apella Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 9 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.